STORM Therapeutics

Cambridge (UK) cancer drug developer whose lead candidate STC-15, a METTL3 inhibitor, is in a Phase 2 sarcoma trial.

View on the globe

$56MEquity raised in 2025–20262025 — · 2026 $56M · 1 equity round
$56MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 16 Apr 2026 to 16 Apr 2026, $56M equity disclosed. Earlier rounds exist but are not sourced.16 Apr 2026: Series C, $56M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ42026Q2Q3Q42027Equity round16 Apr 2026 · Series C · $56MSeries C · $56M
Funding history: 1 round from 16 Apr 2026 to 16 Apr 2026, $56M equity disclosed. Earlier rounds exist but are not sourced.16 Apr 2026: Series C, $56M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourcedQ42026Q2Q3Q42027Equity round16 Apr 2026 · Series C · $56M$56M

Funding history 1 round · 3 sources

Earlier rounds not yet sourced. STORM Therapeutics raised before 16 Apr 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series C
    Amount$56M
    Post-money—
    ✓ Confirmed
    Also
    M Ventures, Pfizer Ventures, Taiho Ventures, IP Group plc, UTokyo Innovation Platform Co., Ltd., Fast Track Initiative (FTI)
    Note
    Series C, $56M, dateline 16 Apr 2026 (M Ventures page metadata shows 17 Apr). Release and both secondary reports say the round was funded by existing investors; no lead named. No valuation stated (pre- or post-money). Pfizer Ventures is named on the fetched release and in both secondary reports, so it is included. Earlier rounds not sourced.
    Sources
  2. Earlier rounds not yet sourced

Investors 6

  • Fast Track Initiative (FTI)
  • IP Group plc
  • M Ventures
  • Pfizer Ventures
  • Taiho Ventures
  • UTokyo Innovation Platform Co., Ltd.

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the Cambridge hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. STORM Therapeutics and its logo are trademarks of their owners, used here for identification only.